Cushing’s syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia

Endogenous Cushing’s syndrome (CS) is associated with increased morbidity and mortality. Early diagnosis and initiation of therapy are essential, but effective treatment remains a challenge. In a long-term follow-up, biochemical control of hypercortisolemia, especially when severe, is difficult to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzialach, Lukasz, Sobolewska, Joanna, Respondek, Wioleta, Wojciechowska-Luzniak, Agnieszka, Witek, Przemyslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Teaching Case Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712315/
https://www.ncbi.nlm.nih.gov/pubmed/36129663
http://dx.doi.org/10.1007/s42000-022-00397-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712315/
https://www.ncbi.nlm.nih.gov/pubmed/36129663
http://dx.doi.org/10.1007/s42000-022-00397-4

Ejemplares similares